Research progress on exosomederived noncoding RNAs in liquid biopsy of hepatocelluar carcinoma

Abstract

Zhang Fangyong, Wu Fan. Research progress on exosomederived noncoding RNAs in liquid biopsy of hepatocelluar carcinoma[J]. Journal of International Oncology, 2019, 46(6): 378-381.

［1］ Kaikkonen MU, Adelman K. Emerging roles of noncoding RNA transcription［J］. Trends Biochem Sci, 2018, 43(9): 654-667. DOI: 10.1016/j.tibs.2018.06.002. ［2］ Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis［J］. Cell Res, 2015, 25(8): 981-984. DOI: 10.1038/cr.2015.82. ［3］ Huang X, Yuan T, Liang M, et al. Exosomal miR-1290 and miR-375 as prognostic markers in castrationresistant prostate cancer［J］. Eur Urol, 2015, 67(1): 33-41. DOI: 10.1016/j.eururo.2014.07.035. ［4］ Wang H, Hou L, Li A, et al. Expression of serum exosomal micro-RNA-21 in human hepatocellular carcinoma［J］. Biomed Res Int, 2014, 2014: 864894. DOI: 10.1155/2014/864894. ［5］ Sugimachi K, Matsumura T, Hirata H, et al. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation［J］. Br J Cancer, 2015, 112(3): 532-538. DOI: 10.1038/bjc.2014.621. ［6］ Lee YR, Kim G, Tak WY, et al. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma［J］. Int J Cancer, 2018, 144(6): 1444-1452. DOI: 10.1002/ijc.31931. ［7］ Sohn W, Kim J, Kang SH, et al. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma［J］. Exp Mol Med, 2015, 47: e184. DOI: 10.1038/emm.2015.68. ［8］ Xue X, Zhao Y, Wang X, et al. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma［J］. J Cell Biochem, 2019, 120(1): 135-142. DOI: 10.1002/jcb.27165. ［9］ Qu Z, Wu J, Wu J, et al. Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis［J］. Oncotarget, 2017, 8(46): 80666-80678. DOI: 10.18632/oncotarget.20881. ［10］ Wang Y, Zhang C, Zhang P, et al. Serum exosomal microRNAs combined with alphafetoprotein as diagnostic markers of hepatocellular carcinoma［J］. Cancer Med, 2018, 7(5): 1670-1679. DOI: 10.1002/cam4.1390. ［11］ Liu W, Hu J, Zhou K, et al. Serum exosomal miR125b is a novel prognostic marker for hepatocellular carcinoma［J］. Onco Targets Ther, 2017, 10: 3843-3851. DOI: 10.2147/OTT.S140062. ［12］ Tang J, Li Y, Liu K, et al. Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma［J］. Minerva Med, 2018, 109(1): 15-23. DOI: 10.23736/S0026-4806.17.05167-9. ［13］ Shi M, Jiang Y, Yang L, et al. Decreased levels of serum exosomal miR638 predict poor prognosis in hepatocellular carcinoma［J］. J Cell Biochem, 2018, 119(6): 4711-4716. DOI: 10.1002/jcb.26650. ［14］ Revenfeld AL, Baek R, Nielsen MH, et al. Diagnostic and prognostic potential of extracellular vesicles in peripheral blood［J］. Clin Ther, 2014, 36(6): 830-846. DOI: 10.1016/j.clinthera.2014.05.008. ［15］ Dong L, Lin W, Qi P, et al. Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for diagnosis of colorectal cancer［J］. Cancer Epidemiol Biomarkers Prev, 2016, 25(7): 1158-1166. DOI: 10.1158/1055-9965.EPI-16-0006. ［16］ Zhou R, Chen KK, Zhang J, et al. The decade of exosomal long RNA species: an emerging cancer antagonist［J］. Mol Cancer, 2018, 17(1): 75. DOI: 10.1186/s12943-018-0823-z. ［17］ Sun L, Su Y, Liu X, et al. Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma［J］. J Cancer, 2018, 9(15): 2631-2639. DOI: 10.7150/jca.24978. ［18］ Li B, Mao R, Liu C, et al. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells［J］. Life Sci, 2018, 197: 122-129. DOI: 10.1016/j.lfs.2018.02.006. ［19］ Zhang C, Yang X, Qi Q, et al. lncRNAHEIH in serum and exosomes as a potential biomarker in the HCVrelated hepatocellular carcinoma［J］. Cancer Biomark, 2018, 21(3): 651-659. DOI: 10.3233/CBM-170727. ［20］ Xu H, Chen Y, Dong X, et al. Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma［J］. Cancer Epidemiol Biomarkers Prev, 2018, 27(6): 710-716. DOI: 10.1158/1055-9965.EPI-17-0770. ［21］ Hou Y, Yu Z, Tam NL, et al. Exosomerelated lncRNAs as predictors of HCC patient survival: a prognostic model［J］. Am J Transl Res, 2018, 10(6): 1648-1662. ［22］ Bao C, Lyu D, Huang S. Circular RNA expands its territory［J］. Mol Cell Oncol, 2016, 3(2): e1084443. DOI: 10.1080/23723556.2015.1084443. ［23］ Zhang X, Xu Y, Qian Z, et al. circRNA_104075 stimulates YAPdependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma［J］. Cell Death Dis, 2018, 9(11): 1091. DOI: 10.1038/s41419-018-1132-6. ［24］ Zhang C, Zhang C, Lin J, et al. Circular RNA hsa_circ_0091579 serves as a diagnostic and prognostic marker for hepatocellular carcinoma［J］. Cell Physiol Biochem, 2018, 51(1): 290-300. DOI: 10.1159/000495230. ［25］ Zhang X, Zhou H, Jing W, et al. The circular RNA hsa_circ_0001445 regulates the proliferation and migration of hepatocellular carcinoma and may serve as a diagnostic biomarker［J］. Dis Markers, 2018, 2018: 3073467. DOI: 10.1155/2018/3073467. ［26］ Matboli M, Shafei AE, Ali MA, et al. circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinoma［J］. J Cell Biochem, 2019, 120(5): 7711-7724. DOI: 10.1002/jcb.28045. ［27］ Li X, Shen M. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR620［J］. Eur Rev Med Pharmacol Sci, 2019, 23(2): 555-566. DOI: 10.26355/eurrev_201902_16868. ［28］ Wang G, Liu W, Zou Y, et al. Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449aMET pathway［J］. EBioMedicine, 2019, 40: 432-445. DOI: 10.1016/j.ebiom.2018.12.062.

[1]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[2]	Peng Qin, Cai Yuting, Wang Wei.Advances on KPNA2 in liver cancer[J]. Journal of International Oncology, 2024, 51(3): 181-185.
[3]	Liu Bohan, Huang Junxing.Research progress of liquid biopsy technology in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(2): 105-108.
[4]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.
[5]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells[J]. Journal of International Oncology, 2023, 50(9): 513-519.
[6]	Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.Current status of research on exosomes in malignancies[J]. Journal of International Oncology, 2023, 50(8): 484-488.
[7]	Li Jiaxuan, Feng Yinglu.Mechanism of action of glucocorticoid receptors in the growth of hepatoma cells[J]. Journal of International Oncology, 2023, 50(4): 241-243.
[8]	He Ting, Wang Xi, Zhang Huizhong, Liu Xinyang, Wang Huiping, Dong Ke.Diagnostic value of serum TIM-3 in patients with liver cancer[J]. Journal of International Oncology, 2022, 49(9): 537-542.
[9]	Zhang Junpeng, Yu Yanyan, Li Baosheng.Mechanism of lncRNA and circRNA regulating the sensitivity of radiotherapy and chemotherapy in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(3): 185-189.
[10]	Li Hongyu, Wu Xinlin.Exosomes and liver metastasis of colorectal cancer[J]. Journal of International Oncology, 2022, 49(12): 749-753.
[11]	Zhang Yumin, Zhao Xianwei, He Qianjin, Chen Jieneng.Value of contrast-enhanced ultrasound combined with serum CXCL8 and CXCR2 in the evaluation of postoperative efficacy of transcatheter arterial chemoembolization for primary liver cancer[J]. Journal of International Oncology, 2022, 49(10): 592-596.
[12]	Wang Wenhao, Sun Xirui, Liu Jin, Sun Xiumei.Role of cancer-associated fibroblasts in the development and progression of breast cancer[J]. Journal of International Oncology, 2022, 49(10): 615-618.
[13]	Di Weihua, Zhao Xuemei.Research progress on the relationship between DNA damage repair genes and liver cancer[J]. Journal of International Oncology, 2022, 49(10): 635-638.
[14]	Zhang Wanchen, Xu Jiajie, Zhang Lizhuo, Ge Minghua.Clinical significance of exosomal-circRNA in tumor diagnosis and treatment[J]. Journal of International Oncology, 2021, 48(9): 549-552.
[15]	Du Jiahang, Chen Dong, Chen Yaoting.Research progress of arsenic trioxide in anti-liver cancer mechanism and treatment of hepatocellular carcinoma[J]. Journal of International Oncology, 2021, 48(9): 572-.

Research progress on exosomederived noncoding RNAs in liquid biopsy of hepatocelluar carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments